This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Vanderbilt University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Sergey I Dikalov
Introduction
Sergey I Dikalov is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that target mitochondrial function. His work is essential for advancing our understanding of cellular processes and potential therapeutic applications.
Latest Patents
Dikalov holds a patent for "Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof." This patent focuses on the use of novel 2-hydroxybenzylamine derivatives as scavengers of isolevuglandins. His innovative approach has the potential to impact various medical fields, particularly in treating conditions related to mitochondrial dysfunction.
Career Highlights
Dikalov is affiliated with Vanderbilt University, where he conducts research and collaborates with other scientists. His work has garnered attention for its implications in health and disease, showcasing his commitment to advancing scientific knowledge.
Collaborations
One of his notable collaborators is Venkataraman Amarnath. Together, they contribute to the research community, exploring new avenues in biochemistry and related fields.
Conclusion
Sergey I Dikalov's contributions to science through his patent and research at Vanderbilt University highlight the importance of innovation in addressing complex biological challenges. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile